NYSE:GEN - Genesis Healthcare Stock Price, Forecast & News

Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN."

Genesis Healthcare Inc (NYSE:GEN) released its quarterly earnings results on Thursday, November, 7th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.09) by $0.49. The firm had revenue of $1.12 billion for the quarter, compared to analyst estimates of $1.13 billion. View Genesis Healthcare's Earnings History.

Genesis Healthcare is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Genesis Healthcare.

Media headlines about GEN stock have been trending extremely negative recently, InfoTrie Sentiment reports. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Genesis Healthcare earned a news sentiment score of -5.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Genesis Healthcare.

Some companies that are related to Genesis Healthcare include Opko Health (OPK), Knight Therapeutics (GUD), Akebia Therapeutics (AKBA), Enanta Pharmaceuticals (ENTA), Cryolife (CRY), Dermira (DERM), Adverum Biotechnologies (ADVM), ImmunoGen (IMGN), Inogen (INGN), BAVARIAN NORDIC/S (BVNRY), Odonate Therapeutics (ODT), Varex Imaging (VREX), Applied Therapeutics (APLT), Axonics Modulation Technologies (AXNX) and Kiniksa Pharmaceuticals (KNSA).

Based on aggregate information from My MarketBeat watchlists, some companies that other Genesis Healthcare investors own include Flaherty&Crumrine Prfrd Scts Incm Fd (FFC), Vaxart (VXRT), Advanced Micro Devices (AMD), Amarin (AMRN), Anavex Life Sciences (AVXL), Government Properties Income Trust (GOV), Inovio Pharmaceuticals (INO), Aduro BioTech (ADRO), Agile Therapeutics (AGRX) and TrovaGene (TROV).

Genesis Healthcare's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include First Washington CORP (2.54%), Renaissance Technologies LLC (2.53%), Chevy Chase Trust Holdings Inc. (1.59%), Acadian Asset Management LLC (0.98%), State Street Corp (0.73%) and Panagora Asset Management Inc. (0.59%). Company insiders that own Genesis Healthcare stock include David A Reis, Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach, Stephen Scott Young and Thomas Divittorio. View Institutional Ownership Trends for Genesis Healthcare.

GEN stock was sold by a variety of institutional investors in the last quarter, including BSW Wealth Partners, Goldman Sachs Group Inc., Virtu Financial LLC, California Public Employees Retirement System and Principal Financial Group Inc.. Company insiders that have sold Genesis Healthcare company stock in the last year include Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach and Thomas Divittorio. View Insider Buying and Selling for Genesis Healthcare.

GEN stock was bought by a variety of institutional investors in the last quarter, including First Washington CORP, Renaissance Technologies LLC, Chevy Chase Trust Holdings Inc., Panagora Asset Management Inc., State Street Corp, Acadian Asset Management LLC, Barclays PLC and UBS Group AG. View Insider Buying and Selling for Genesis Healthcare.

Shares of GEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of GEN stock can currently be purchased for approximately $1.61.

Genesis Healthcare has a market capitalization of $265.33 million and generates $4.98 billion in revenue each year. The company earns $-235,230,000.00 in net income (profit) each year or ($1.55) on an earnings per share basis. Genesis Healthcare employs 61,300 workers across the globe.View Additional Information About Genesis Healthcare.

The official website for Genesis Healthcare is http://www.genesishcc.com/.

Genesis Healthcare's mailing address is 101 EAST STATE STREET, KENNETT SQUARE PA, 19348. The company can be reached via phone at 610-444-6350 or via email at [email protected]